Page last updated: 2024-10-30

metformin and Cancer of Endocrine Gland

metformin has been researched along with Cancer of Endocrine Gland in 2 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin treatment has been associated with better response to cancer therapy in thyroid cancer and pNETs."2.61The role of an anti-diabetic drug metformin in the treatment of endocrine tumors. ( Daley, B; Klubo-Gwiezdzinska, J; Thakur, S, 2019)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
León-González, AJ1
Jiménez-Vacas, JM1
Fuentes-Fayos, AC1
Sarmento-Cabral, A1
Herrera-Martínez, AD1
Gahete, MD1
Luque, RM1
Thakur, S1
Daley, B1
Klubo-Gwiezdzinska, J1

Reviews

2 reviews available for metformin and Cancer of Endocrine Gland

ArticleYear
Role of metformin and other metabolic drugs in the prevention and therapy of endocrine-related cancers.
    Current opinion in pharmacology, 2021, Volume: 60

    Topics: Diabetes Mellitus, Type 2; Endocrine Gland Neoplasms; Humans; Hypoglycemic Agents; Insulin; Metformi

2021
The role of an anti-diabetic drug metformin in the treatment of endocrine tumors.
    Journal of molecular endocrinology, 2019, Volume: 63, Issue:2

    Topics: Animals; Diabetes Mellitus; Endocrine Gland Neoplasms; Humans; Hypoglycemic Agents; Metformin; Signa

2019